Gerard M Bredael

Title: Gerard M Bredael: Innovator in Pharmaceutical Composition

Introduction

Gerard M Bredael is a notable inventor based in Portage, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on improving the delivery and effectiveness of medications.

Latest Patents

Gerard holds a patent for a formulation titled "Pramipexole once-daily dosage form." This orally deliverable pharmaceutical composition includes a therapeutically effective amount of pramipexole or a pharmaceutically acceptable salt thereof, along with at least one pharmaceutically acceptable excipient. The composition is designed to exhibit specific in vitro and in vivo release profiles, making it suitable for oral administration not more than once daily to patients requiring a dopamine receptor agonist.

Career Highlights

Gerard M Bredael has been associated with Pharmacia Corporation, where he has contributed to various pharmaceutical innovations. His expertise in drug formulation has led to advancements that enhance patient compliance and therapeutic outcomes.

Collaborations

Throughout his career, Gerard has worked alongside esteemed colleagues such as Steven R Cox and John R Baldwin. Their collaborative efforts have fostered a productive environment for innovation in pharmaceutical research.

Conclusion

Gerard M Bredael's contributions to the field of pharmaceuticals, particularly through his patent on pramipexole dosage forms, highlight his role as an influential inventor. His work continues to impact the development of effective medication delivery systems.